Pipeline

Focused on Neurodegenerative Disease and Psychiatric Disorder

Indication

Phase II a

Phase II b

Phase III

Alzheimer's Disease:  

Anxiety/Sleep

Depression

Active

Complete

Complete

Complete

Concussion

Schizophrenia

Complete

Active

Planned

Planned

Planned

Planned

 

Clinical Trials

 
 

*L-TAMS is API of MMFS series of products under development

Neurocentria, Inc.

1855 Olympic Blvd., Ste. 225 Walnut Creek, CA., U.S.A.  94596

info@neurocentria.com

925-954-4868

2018 Neurocentria, Inc.